A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients
Top Cited Papers
Open Access
- 1 April 2022
- journal article
- research article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 22 (4), 1253-1260
- https://doi.org/10.1111/ajt.16933
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases (HHSN272201400007C, K08AI156021, K23AI157893, K24AI144954, R01AI120938S1)
- National Cancer Institute (U54CA260491)
- National Institute of Diabetes and Digestive and Kidney Diseases (F32DK124941, K23DK115908, T32DK007713)
This publication has 25 references indexed in Scilit:
- Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing TitersJournal of Clinical Microbiology, 2021
- COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literatureTransplantation Reviews, 2020
- Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor populationJCI Insight, 2020
- Distinct Early Serological Signatures Track with SARS-CoV-2 SurvivalImmunity, 2020
- Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2Emerging Infectious Diseases, 2020
- COVID-19 in Immunocompromised Hosts: What We Know So FarClinical Infectious Diseases, 2020
- Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cellsProceedings of the National Academy of Sciences of the United States of America, 2020
- An immunosuppressed Syrian golden hamster model for SARS-CoV infectionVirology, 2008
- Severe Acute Respiratory Syndrome Coronavirus Gene 7 Products Contribute to Virus-Induced ApoptosisJournal of Virology, 2007
- The ORF7b Protein of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Is Expressed in Virus-Infected Cells and Incorporated into SARS-CoV ParticlesJournal of Virology, 2007